Table 6 Pre-Post Differences in Patient Management for Elevated BP (SBP≥140 and/or DBP ≥90) (Patient Direct Observation)

Laboratory Testing

n(%)

n(%)

Pt was prescribed lab tests

46(68.7)

75(79.8)*

Pt received information about the lab tests

37(80.4)

50(66.7)

Type of test ordered

N=46

N=75

Lipid profile

3(6.5)

30(40.0)***

Renal function test

2(4.4)

4(5.3)

Sodium

0(0.0)

35(46.7)***

Blood Sugar

14(30.4)

37(49.3)*

ECG

6(13.0)

22(29.3)*

Other (Malaria, Xray, MRDT, Hb, Cervical screening, Urine analysis, FBR, ESR, HIV Test)

31(67.4)

42(56.0)

Pt was prescribed antihypertensive medications

29(43.3)

41(43.6)

Hydrochlothiazide

1(3.5)

3(7.3)

Bendroflumethiazide

5(17.2)

3(7.3)

Furosemide

10(34.5)

12(29.3)

Atenolol

2(6.9)

11(26.8)

Nifedipine

15(51.7)

27(65.9)

Amlodipine

1(3.5)

8(19.5)

Repace-H (combination of “Losartan potassium 50mg and hydrochlorothiazide 12.5mg”

2(6.9)

2(4.9)

Patient received counseling:

N=29

N=41

medication regimen (dose and timing)

18(62.1)

38(92.7)**

potential side effects of medication

12(41.4)

23(56.1)**

importance of taking the medication

23(79.3)

39(95.1)*

where to obtain the medication

28(96.6)

41(100)

Dietary Counseling

N=29

N=41

Reduce salt in cooking

19(65.5)

40(97.6)**

Reduce table salt consumption

17(58.6)

40(97.6)***

Reduce consumption of foods rich in sodium

23(79.3)

39(95.1)*

Reduce caloric intake

20(69.0)

39(95.1)**

Increase physical activity or exercise

16(55.2)

38(92.7)***

Cease or reduce smoking

7(24.1)

26(63.4)**

Cease or reduce alcohol consumption

7(24.1)

28(68.3)***

Received assistance on follow up appointments

23(79.3)

39(95.1)*

Referred to the next level (hospital/health center)

4(13.8)

20(48.8)***